2025-12-03 - Analysis Report
Okay, here's a comprehensive report on Chevron (CVX) based on the provided data.

**1) Return Rate Comparison & Alpha/Beta Analysis**

*   **Company Overview:** Chevron Corp. is an integrated energy company involved in the exploration, production, and transportation of crude oil and natural gas.
*   **Cumulative Return:**
    *   CVX: 34.69%
    *   VOO (S&P 500): 100.36%
*   **Divergence:**
    *   Current: -65.9
    *   Relative Divergence: 0.3 (Near the minimum of its historical range)

*   **Alpha, Beta, CAGR, MDD Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
|------------|---------|---------|---------|-------|--------|
| 2015-2017  | 33.0%   | 65.9%   | 5.0%    | 0.1   | 252.2  |
| 2016-2018  | 21.0%   | 71.9%   | 6.0%    | 0.2   | 219.2  |
| 2017-2019  | 3.0%    | 71.9%   | -19.0%  | 0.9   | 242.8  |
| 2018-2020  | -10.0%  | 79.6%   | -33.0%  | 0.7   | 170.1  |
| 2019-2021  | 22.0%   | 79.6%   | -25.0%  | 0.6   | 236.4  |
| 2020-2022  | 85.0%   | 83.2%   | 86.0%   | 0.3   | 361.6  |
| 2021-2023  | 49.0%   | 83.2%   | 47.0%   | 0.4   | 300.5  |
| 2022-2024  | -6.0%   | 83.2%   | -26.0%  | 0.2   | 291.8  |
| 2023-2025  | -47.0%  | 74.8%   | -112.0% | 0.6   | 302.1  |

*   **Analysis:** Chevron has significantly underperformed the S&P 500 in cumulative return.  The relative divergence of 0.3 indicates that this underperformance is near the worst it has been over the considered period. The alpha values are quite volatile, sometimes exceeding market performance and sometimes falling far short. The last period shows a very negative Alpha, which means it lagged significantly from S&P 500. The beta has been consistently below 1, suggesting Chevron has been less volatile than the overall market, but it has fluctuated a bit.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 149.97
*   **Last Market Data:** Price: 149.94, Previous Close: 152.54, Change: -1.7
*   **Moving Averages:**
    *   5-day SMA: 149.778
    *   20-day SMA: 152.793
    *   60-day SMA: 154.5348

*   **Analysis:** The stock is trading below its 5-day, 20-day, and 60-day Simple Moving Averages, suggesting a short-term downtrend.  The recent price change of -1.7 indicates a decline from the previous close.

**3) RSI, PPO, and Market Indicators**

*   **MRI (Market Risk Indicator):** 0.9 (Medium Investment Recommended)
*   **RSI (Relative Strength Index):** 36.25 (Approaching oversold territory)
*   **PPO (Percentage Price Oscillator):** -0.2599
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (12 shares - Safe - MRI:0.80) Dividend_1.71 (Cash Ratio: 0% on 2025-11-18)
*   **Recent Relative Divergence Change (20 days):** -6.1 (Short-term decline)
*   **Expected Return:** 994.9% (Expected excess return compared to S&P 500 if invested long-term)

*   **Analysis:** The RSI is approaching oversold, which *could* signal a potential buying opportunity, but this should be viewed in conjunction with other indicators.  The PPO is negative, supporting the downward price movement.  The hybrid signal suggests buying and a low cash ratio. The MRI suggests medium investment risk, somewhat contradicting the RSI, which indicates oversold conditions. A notable divergence change indicates it's on a short-term decline. The extremely high expected return should be taken with caution, as it might be based on specific model assumptions.

**4) Recent News & Significant Events**

*   **Key Headlines:**
    *   Evaluating Chevron (CVX) Stock's Actual Performance (Motley Fool, Yahoo Finance)
    *   UBS reiterates Buy rating on Chevron stock with $197 price target (Investing.com)
    *   Chevron Corporation $CVX Shares Purchased by Brandes Investment Partners LP (MarketBeat)
    *   Chevron Stock (CVX) Today: HSBC Upgrade, Nigeria Deal, Drone Risk and 2030 Cashâ€‘Flow Plan (ts2.tech)
    *   New Analyst Forecast: $CVX Given $169 Price Target (Quiver Quantitative)

*   **Analysis:** The news is a mixed bag. While UBS reiterated a "Buy" rating, other articles discuss performance evaluation and new analyst forecasts, some of which are lower ($169 price target).  The news mentions both positive developments (Nigeria deal, analyst upgrades) and potential risks (drone risk).  The purchase by Brandes Investment Partners is a positive signal.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.07) based on 25 opinions.
*   **Target Price:**
    *   Average: $172.92
    *   High: $204.00
    *   Low: $124.00
*   **Recent Rating Changes:** Not provided.

*   **Analysis:** The analyst consensus is generally positive, with a "Buy" rating. The average target price suggests potential upside from the current price. The range in target prices indicates a degree of uncertainty among analysts.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-11-06 | 1.83 | 48.17 B$    |
| 2025-08-07 | 1.45 | 44.38 B$    |
| 2025-05-08 | 2.01 | 46.10 B$    |
| 2024-11-07 | 2.49 | 48.93 B$    |
| 2025-11-06 | 2.49 | 48.93 B$    |

*   **Analysis:** Recent EPS has fluctuated. There appears to be a repeat of 2024-11-07 data for 2025-11-06, which is likely an error.  Revenue has also fluctuated but generally remained in a relatively stable range around $44-$49 billion. Overall, the company seems to be doing well from a revenue perspective, though it seems there is some volatility with the earnings.

**6) Financial Information**

Revenue and Profitability:

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30 | $48.17B  | 31.12%       |
| 2025-06-30 | $44.38B  | 29.69%       |
| 2025-03-31 | $46.10B  | 29.00%       |
| 2024-12-31 | $48.33B  | 27.34%       |
| 2024-09-30 | $48.93B  | 29.15%       |

Capital and Profitability:

| Quarter      | Equity      | ROE      |
|--------------|-------------|----------|
| 2025-09-30 | $189.84B    | 1.86%    |
| 2025-06-30 | $146.42B    | 1.70%    |
| 2025-03-31 | $149.24B    | 2.35%    |
| 2024-12-31 | $152.32B    | 2.13%    |
| 2024-09-30 | $156.20B    | 2.87%    |

*   **Analysis:** Revenue has been relatively stable. Profit margins are healthy, generally above 27%, and are even trending upwards in the latest quarter. Equity shows some volatility, increasing significantly in the latest quarter.  ROE (Return on Equity) has fluctuated, but has recently decreased in the most recent quarter even though equity increased by a large amount.

**7) Comprehensive Analysis (Summary)**

Chevron is currently facing mixed signals.

*   **Negative Indicators:**
    *   Significantly underperforming the S&P 500 over the considered period.
    *   Short-term price downtrend (below moving averages).
    *   Negative PPO.
    *   Recent negative divergence change.
*   **Positive Indicators:**
    *   MRI suggests "Medium Investment".
    *   Analyst consensus is "Buy."
    *   Healthy profit margins.
    *   Brandes Investment Partners purchased shares.
    *   The high expected return.
*   **Mixed Indicators:**
    *   The RSI is nearing oversold. This can be viewed as either a potential buying opportunity or an indicator that the company might be trending downward.
    *   Recent News is a mixed bag of price targets, performance discussions, and risk factors.

**Overall Recommendation:** Given the mixed signals, a cautious approach is advised. Investors should carefully weigh the positive and negative indicators, consider their risk tolerance, and conduct further research before making an investment decision. The extremely high 'expected return' should be validated against more conservative models and expectations for the energy sector. The recent news and analyst opinions should be considered alongside the company's financial performance and market indicators.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.